Industry-Wide Solutions to Improve Access to Clinical Trials
Increasing diversity and inclusion in research has long been a challenge in the clinical research community. Barriers to access can impact efficacy of future treatments and exclude underserved populations from quality clinical care. Understanding this vital, pervasive issue can enable sponsors, sites, CROs, and vendors to make clinical research more inclusive for all.
In this panel discussion shared at Advarra’s Spring Onsemble conference, representatives from Yale University, Parexel, and Par8o provide actionable strategies for improving access to clinical research for diverse, underserved populations. The panelists will provide both site and CRO perspectives on how to address key barriers such as lack of access to research sites, challenges developing educational materials to adequately reach potential participants, optimizing trial design to accommodate a diverse population, and more.
Learning Objectives:
- Share site and CRO perspectives on barriers to access
- Analyze how to optimize trial design to accommodate a diverse population
- Discuss strategies for community building, ambassador programs, and referral models
Presented By
Gadi Saarony
Chief Executive Officer
Advarra
Tesheia Harris
MBA, MHS
Deputy Director and Chief Operating Officer/Director of Clinical Research
Yale Center for Clinical Investigation/Yale School of Medicine
Peyton Howell
President, Commercial and Consulting and Chief Commercial & Strategy Officer
Parexel
Melissa Palchak Opraseuth
PharmD
Chief Operating Officer
par8o, Inc.
DATE: April 1, 2021
Time: 1 pm ET | 10 am PT
Duration: 1 hour